Brevicon 1/35 Tablets (21-Day Pack) 1 mg (Norethindrone TABLET) 1 MG

BREVICON 1/35 tablets are a combination oral contraceptive containing norethindrone, used for birth control. This 21-day pack helps prevent pregnancy with a 1 mg strength per tablet.

Strength

1 MG

Pack Size

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

BREVICON 1/35 tablets are primarily used for birth control. This oral contraceptive works by preventing ovulation and altering the cervical mucus to hinder sperm movement. Women may also use norethindrone for managing menstrual cycles or treating conditions like endometriosis, but always consult a healthcare provider for personalized advice.

Side Effects

Common effects of BREVICON 1/35 tablets may include changes in menstrual bleeding patterns, such as lighter or shorter periods. Some users might experience nausea, breast tenderness, or headaches. These effects vary and typically subside as the body adjusts to the medication.

Precautions & Warnings

Handle BREVICON 1/35 tablets with care, storing them at room temperature away from moisture and heat. Follow the prescribed schedule closely, and do not skip doses. Inform your healthcare provider about any existing medical conditions or allergies before starting this medication.

Avoid Interactions

BREVICON 1/35 tablets may interact with certain medications, including antibiotics, anticonvulsants, and HIV drugs. Alcohol and other substances can also affect its efficacy. Always consult a healthcare provider before combining norethindrone with other treatments.

Frequently Asked Questions

BREVICON 1/35 tablets are primarily used for birth control and managing menstrual cycles.

Follow the prescribed schedule provided by your healthcare provider, typically taking one tablet daily for 21 days.

Common side effects may include changes in menstrual bleeding, nausea, breast tenderness, and headaches.

Alcohol may interact with BREVICON 1/35 tablets. Consult your healthcare provider for personalized advice.

If you miss a dose, follow the instructions provided by your healthcare provider or the medication guide.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.